Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Tricopat Global markets a CE-marked medical device for non-invasive scalp therapy. Clinical studies and patient evaluations report significant improvements in hair density and appearance after several sessions. The technology is used in clinics across Europe and has recently expanded to the US market. It is positioned as an effective, painless alternative to traditional mesotherapy or injectable treatments for androgenetic alopecia and telogen effluvium.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Tricopat Global.